The Missouri Court of Appeals appeared disinclined to question a jury’s $4.7 billion talcum powder verdict but raised numerous jurisdictional questions about why the case against New Jersey-based Johnson & Johnson was in Missouri.

The case involved 22 women and their families alleging Johnson & Johnson’s baby powder, which contained asbestos, caused them to get ovarian cancer. On Friday, Johnson & Johnson attorney Thomas Weaver argued to reverse the verdict, focusing in large part on the fact that the judge should never have joined the claims of so many plaintiffs into a single trial, particularly since 17 of them were not from Missouri. He claimed that doing so prejudiced the jury, which awarded $25 million in compensatory damages to each plaintiff in 2018.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]